Page Added:

dummie text

view your clipboard
Page added to clipboard.

Dr. Bruce Shares Updates on Glioblastoma During CancerCare Teleconference

Dr. Bruce glioblastoma teleconference

“This is an exciting time to be in the brain tumor field, as there are many new advances in the treatment and diagnosis of glioblastoma,” said Dr. Jeffrey N. Bruce recently to an audience of more than 350 dialed in for a CancerCare teleconference.

“In fact, there are more scientists working on brain tumors now than at any time in our history.”

Though miles, states and even oceans apart, participants tuned in to listen to Dr. Bruce of the Brain Tumor Center at Columbia University Medical Center/NewYork-Presbyterian Hospital.

He and two other panelists spoke at a free one-hour CancerCare Connect Education Workshop titled “Update on Glioblastoma”—a deadly and aggressive type of brain tumor.

CancerCare Connect Education Workshops are hosted as teleconferences, providing people around the world with access to advice from a panel of experts and the opportunity to ask questions.

This particular teleconference drew participants from not only the United States but other countries too, including Australia, Sweden and Costa Rica. (To browse or sign up for upcoming events, visit the CancerCare website.)

For the past 20 years, brain tumor expert Dr. Bruce has helped CancerCare, a national nonprofit organization dedicated to serving patients with cancer, their families and caregivers, as well as other healthcare professionals. CancerCare not only organizes teleconferences but also provides other forms of education and services such as counseling, support groups and financial assistance.

“This organization has been very helpful for many patients and their families,” Dr. Bruce explained during the teleconference, “and they really offer a great service by educating and providing support.”

During the “Update on Glioblastoma” teleconference, Dr. Bruce gave an overview of glioblastoma, including current standard of care, and discussed novel treatment approaches, some of which are in use and others that are still in the pipeline.

He also explained the importance of clinical trials—research studies where volunteer patients receive a treatment not yet approved by the U.S. Food and Drug Administration for general use—and the benefits of joining one. Lastly, he discussed how crucial it is to communicate quality-of-life concerns to your healthcare team and suggested ways to do that.

This was not the first CancerCare teleconference Dr. Bruce has been involved in. In June of last year, he shared the highlights of the latest brain tumor research presented at the 2015 American Society of Clinical Oncology (ASCO) annual meeting.

Dr. Bruce’s expertise in the treatment of glioblastoma is likely what attracted participants to the teleconference, but he also offered some heartwarming advice:

“Just because you have a brain tumor, no one is saying you can’t visit a mall or enjoy your birthday party or have a nice meal or see a movie. It’s important to continue to live your life to the highest degree possible, despite any diagnosis or side effects you may be suffering,” Dr. Bruce encouraged participants. “This is by far the best way to cope with your tumor.”

Learn more about Dr. Bruce at his bio page here.

patient journey

Use this button to save pages to your clipboard for future use.

OK. Got it.